This inventor holds 1 USPTO granted patent. Top assignees: Ascentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Group Corp Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 29 Years Active: 2026
Title: Zongbin Li: Innovator in Pharmaceutical Compounds
Introduction
Zongbin Li is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating diseases related to the hepatitis virus. His innovative work has the potential to impact drug development in the future.
Latest Patents
Zongbin Li holds a patent for "Crystalline forms or amorphous forms of bisdiazabicyclic compounds or salts thereof." This patent focuses on the treatment and prevention of diseases or disorders related to the hepatitis virus. The crystalline and amorphous forms he has developed provide important reference value for future drug development and utilization.
Career Highlights
Throughout his career, Zongbin Li has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Zongbin Li's contributions to pharmaceutical innovations, particularly in the treatment of hepatitis virus-related disorders, highlight his role as a significant inventor in the field. His work continues to pave the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile